Clinical Trial Update: GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia

View source ↗

Summary

The trial evaluated incretin hormones GIP, GLP-1, and GLP-2 in individuals with Type 2 Diabetes Mellitus and is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Herlev Hospital | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED